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Abstract
The Shoc2 protein has been implicated in the positive regulation of the Ras-ERK
pathway by increasing the functional binding interaction between Ras and Raf,
leading to increased ERK activity. Here we found that Shoc2 overexpression
induced sustained ERK phosphorylation, notably in the case of EGF stimulation,
and Shoc2 knockdown inhibited ERK activation. We demonstrate that ectopic
overexpression of human Shoc2 in PC12 cells significantly promotes neurite
extension in the presence of EGF, a stimulus that induces proliferation rather than
differentiation in these cells. Finally, Shoc2 depletion reduces both NGF-induced
neurite outgrowth and ERK activation in PC12 cells. Our data indicate that Shoc2 is
essential to modulate the Ras-ERK signaling outcome in cell differentiation
processes involved in neurite outgrowth.
Introduction
PC12 cells, which are derived from a rat pheochromocytoma, have been used
classically as a model to address the biological outcomes due to functional
differences of the extracellular signal-regulated kinase (ERK) signaling pathway
[1, 2]. This cascade, which involves the Raf, MEK and ERK proteins, can be
activated in PC12 cells by two growth factors, epidermal growth factor (EGF) [2],
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and nerve growth factor (NGF) [3, 4], leading to PC12 proliferation and
differentiation, respectively. The duration of ERK signaling is responsible for the
distinct biological effects of EGF and NGF stimulation on PC12 cells [1, 2]. EGF
elicits transient Ras- (and also Rap-) dependent ERK activation [2], yielding PC12
cell proliferation, whereas NGF promotes sustained ERK phosphorylation, which
leads to cell differentiation (neurite outgrowth) [2, 5, 6].
Ras proteins (H-, N-, and K-Ras) operate as molecular switches in signal
transduction cascades, controlling cell proliferation, differentiation and apoptosis.
Ras proteins exist in equilibrium between an active (Ras-GTP) and an inactive
(Ras-GDP) state. The action of growth factors increases cellular Ras-GTP levels,
enabling interaction of this GTPase with its target protein effectors. Activated Ras
stimulates various downstream signaling pathways. A wide range of proteins
interact specifically with the Ras-GTP complex, including Raf proteins, members
of the Ral-GDS family, PI3K, p120GAP, NF1, MEKK1, Rin1, AF-6, PKC-j, and
Nore1 [7]. For example, Ras-GTP binds directly to Raf proteins, inducing their
translocation to membranes where they are activated, in turn triggering induction
of the MEK-ERK cascade. Different scaffold proteins bind several components of
the Ras/Raf/MEK/ERK cascade, providing molecular signaling platforms, and can
thus regulate the Ras-ERK pathway [8, 9].
One of these scaffold proteins is the suppressor of clear homolog (Shoc2) [10],
also known as a suppressor of Ras-8 (Sur8) [11]. Shoc2/Sur8 is a protein
conserved in all metazoans; it has numerous leucine-rich repeats and selectively
binds members of the Ras family [12]. Fluorescence resonance energy transfer
(FRET) imaging and computational modeling studies showed that Shoc2 is
essential for Ras-GTP signaling to ERK, because it accelerates the Ras-Raf
interaction probably by stabilizing a ternary complex formed by all these proteins
[12, 13, 14]. Furthermore, single mutation of Shoc2 causes Noonan-like
syndrome, a type of neuro-cardio-facial-cutaneous disorders, by enhancing ERK
activation [15]. Other group nonetheless proposes an alternative mechanism of
action for Shoc2, by which this scaffold protein forms a ternary complex with the
catalytic subunit of protein phosphatase 1 (PP1c) and M-Ras (a Ras family
member), which promotes Raf activity by dephosphorylating its S259 inhibitory
residue [16], and also forms a complex with SCRIB playing a key role in polarized
migration [17].
Based on Shoc2 function as a positive modulator of the ERK-pathway, we
hypothesized that this scaffold protein might have a pivotal role in PC12 cell
differentiation, a process dependent on sustained ERK activation. Here, we
analyzed how ectopic overexpression of Shoc2 affects EGF signaling in PC12 cells.
Shoc2 overexpression renders longer-lasting ERK phosphorylation after EGF
stimulation, with a resultant increase in neurite outgrowth. We also found
evidence that knockdown of endogenous Shoc2 by specific shRNA leads to
statistically significant inhibition of NGF-induced PC12 cell differentiation. Our
data indicate that the scaffold protein Shoc2 contributes to NGF and EGF-
induced neurite outgrowth in PC12 cells.
Shoc2 Is Essential for PC12 Cell Differentiation
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Material and Methods
Cell lines
HEK293T cells [18] were maintained in DMEM (Invitrogen, Carlsbad, CA)
supplemented with 10% fetal calf serum (FCS, Invitrogen); these cells were
analyzed after bFGF or EGF stimulation as described [18, 19]. PC12 rat
pheochromocytoma cells [1] were cultured on collagen-coated plates using
DMEM supplemented with 7.5% FCS, 7.5% horse serum (Invitrogen), 2 mM
glutamine and 1% penicillin/streptomycin. PC12 cells were allowed to
differentiate for 1-3 days by adding NGF (100 ng/ml) or EGF (100 ng/ml).
Antibodies and reagents
Rabbit polyclonal antibodies to ERK (ERK1/ERK2) were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA); anti-phospho-ERK protein, anti-MEK
(MEK1/MEK2), and anti-p-MEK1/2 were purchased from Cell Signaling
Technology (Beverly, MA), and anti-tubulin was from Covance (Princeton, NJ).
Monoclonal antibodies Anti-C-RAF, anti-pan-Ras, and anti-Grb2 were obtained
from BD Transduction Laboratories (Franklin Lakes, NJ), whereas rabbit
polyclonal anti-Shoc2 was produced and purified in the lab. Anti-HA and AU5
monoclonal antibodies (mAb) were purchased from Berkeley Antibody Company
(Berkeley, CA). Anti b-actin mAb, and recombinant human basic fibroblast
growth factor (bFGF), nerve growth factor (NGF), and epidermal growth factor
(EGF) were from Sigma-Aldrich (St. Louis, MO). Anti-mouse and rabbit HRP-
conjugated mAb were from GE Healthcare Bio-Sciences (Piscataway, NJ).
DNA constructs
The plasmids pCEFL-KZ-HA, pCEFL-KZ-AU5, and pCEFL-KZ-HA-ERK (1 and
2), have been described [18, 19]; the pEGFP-C1 plasmid was purchased from
Invitrogen. The plasmid containing hSur8 was kindly provided by Dr. Min Han
(University of Colorado, Boulder, CO), and Shoc2 cDNA was amplified by PCR
using specific primers providing Bam HI and Not I sites at the 59 and 39 ends,
respectively. The amplified products were then subcloned into Bgl II and Not I
sites within pCEFL-KZ-AU5. SureSilencing plasmids containing different shRNA
for rat Shoc2 and GFP marker were purchased from SA Biosciences
(NM_0011013155): plasmid n˚ 1 (aagctgtcaatcatgagtatt), plasmid n 2˚ (tgaagga-
caatcagttaacat), plasmid n 3˚ (ggtgaactgtgtaacctcatt), and control plasmid
(ggaatctcattcgatgcatac). Small interfering RNA (siRNA) for human Shoc2 were
from Applied Biosystems (Carlsbad, CA). The oligonucleotides synthesized
corresponded to the human Shoc2 encoding region of exon 8.
Transient transfection assays
PC12 cells were nucleofected with shRNA plasmids using the Amaxa kit V (VCA-
1003) following manufacturer’s instructions. PC12 cells were transiently
Shoc2 Is Essential for PC12 Cell Differentiation
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transfected with pCEFL-KZ-AU5-Shoc2 or pCEFL-KZ-HA-ERK-1 plasmids using
Lipofectamine 2000 (Invitrogen) according to manufacturer’s protocols.
HEK293T cells were transiently transfected with pCEFL-KZ-AU5-Shoc2 or
pCEFL-KZ-HA-ERK-1/ERK-2 plasmids using Jet-Pei (Polyplus-Transfection,
Illkirch, France). All assays were performed 48 h post-transfection. The siRNA
duplexes (100 nM) were transfected into HEK293T cells using X-treamGENE
siRNA transfection reagent (Roche, Basel, Switzerland).
Immunoprecipitation and immunoblotting
Immunoprecipitation and immunoblot analysis were performed as described
[18, 19]. Protein extracts were resolved by SDS-PAGE, transferred to nitrocellu-
lose membranes (Schleicher & Schuell) and probed with the appropriate antibody.
Blots were developed by a peroxidase reaction using the ECL detection system (GE
Healthcare Bio-Sciences).
In vitro quantitative detection of intracellular phospho-ERK, total
ERK and other kinases
Total ERK1/2, AKT, and GSK-3b and their phosphorylated forms phospho-
ERK1/2 (pTpY185/187), phospho-AKT (pS473), and phospho-GSK-3b (pS9)
were simultaneously quantitated by xMAP technology on a Luminex 200 platform
(Bio-Plex-200, BioRad) using two independent panels custom developed and
validated by Biosource. For these experiments, PC12 cells were lysed in Cell
Extraction Buffer (Invitrogen) containing 10 mM Tris, pH 7.4, 2 mM Na3VO4,
1 mM EDTA, 100 mM NaCl, 1% Triton X-100, 1 mM EGTA, 20 mM Na4P2O7,
10% glycerol, 1 mM NaF, 0.5% deoxycholate, 0.1% SDS, with protease inhibitors
(Complete from Roche and 1 mM PMSF). Cell extracts (2 mg) were analyzed in
duplicate according to manufacturer’s instructions. The concentration for each
analyte was determined by interpolating the mean fluorescence intensity (MFI)
for each sample from a standard curve using Bio-Plex System Software and a five-
parameter logistic weighting algorithm.
Neurite outgrowth assay
PC12 cells plated onto collagen-coated coverslips in 12-well dishes were
transiently transfected and stimulated with NGF (100 ng/ml) or EGF (100 ng/ml)
for 72 h. Cells were washed with phosphate-buffered saline before and after being
fixed with 4% paraformaldehyde (10 min) and permeabilized with 0.2% Triton
X-100 (10 min). Transfected cells were detected by GFP-fluorescence.
Alternatively, cells were incubated with anti-AU5 mAb (1 h, room temperature).
After several washes, cells were incubated with Alexa 488-conjugated secondary
antibodies (Molecular Probes, Invitrogen; 1 h, room temperature). Cells (50 to
100/condition) were analyzed in a Nikon Eclipse TE200-U microscope. Cells with
and without neurites were then counted. Total neurite length from each cell was
Shoc2 Is Essential for PC12 Cell Differentiation
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measured using ImageJ software (National Institutes of Health). Image capture
and analyses were performed blind to the experimental conditions. Neurite
outgrowth was defined as a process equal to or greater than one cell body in length
for EGF treatment, and equal to or greater than two cell bodies in length for NGF
treatment.
qRT–PCR
GoTaq qPCR Master Mix, from Promega, was used for real time qRT-PCR
analyses. Gene specific pair primers were designed for Shoc2 (Forward: 59-
ATTGTGAGCTACATCCAGCG-3 and Reverse: 59-
TGCTTAGCATTCGAGAGAACA-3) and GADPH (Forward: 59-
AATGAAGGGGTCATTGATGC-39 and Reverse: 59-
AAGGGAAGGTCGGAGTCAA-39) with Primerdepot web. The Applied
Biosystems 7500 fast apparatus was used to run the PCR performed as described
previously [20]. In all cases, GADPH data were used for data normalization.
Results were calculated by the 2-DDCT method.
Statistical analysis
Data were analyzed statistically using the SPSS software (Chicago, IL). Results are
displayed as mean¡ SD of the corresponding number of experiments. Statistical
significance was estimated by Student’s t test for unpaired observations; P,0.05
was considered significant. For immunoblot analysis, we used linear correlations
between increasing levels of protein and its signal intensity.
Results
Ectopic overexpression of Shoc2 facilitates sustained ERK activation after
stimulation by FGF or EGF
Shoc2 has a synergistic effect on activation of the Ras-Raf-MEK-ERK pathway
[12] and is required for rapid Ras interaction with Raf following EGF stimulation
[13]. Here we examined whether Shoc2 overexpression affects the duration of
ERK signaling induced by the stimulation of receptor tyrosine kinases (RTK). For
this purpose, we stimulated HEK293T cells (transiently transfected with HA-
ERK1 and AU5-hShoc2) with FGF or EGF, and measured ERK phosphorylation at
different times. Shoc2 overexpression (with an approximate sixfold increase
averaged over the endogenous Shoc2) raised not only the ERK activation levels
triggered by FGF (Fig. 1A) or EGF (Fig. 1B), but also the duration of this
activation. The kinetics of FGF-induced ERK activation was similar with or
without Shoc2 overexpression but values increased when Shoc2 was overexpressed
(Fig. 1A), whereas phospho-ERK levels were still detected 4 h post-EGF
stimulation in Shoc2-transfected cells but for only 30 min in vector-expressing
cells (Fig. 1B). These results suggest that Shoc2 proteins positively regulate the
Shoc2 Is Essential for PC12 Cell Differentiation
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Fig. 1. Shoc2 overexpression enhances the intensity and/or duration of RTK-elicited ERK activation. HEK293T cells transiently co-transfected with
1 mg pCEFL-KZ-HA-ERK1 and 2 mg pCEFL-KZ-AU5-hShoc2 (S) or 2 mg pCEFL-KZ-AU5 (-) were serum-starved for 18 h and then incubated with vehicle
(0), 25 ng/ml FGF (A), or 10 ng/ml EGF (B), for 5 to 240 min. Cell lysates were immunoprecipitated with anti-HA antibody and analyzed by immunoblot using
anti-p-ERK and -HA antibodies, to determine p-ERK1 and total HA-ERK1. Fold increase denotes the ratio p-ERK/ERK levels estimated as the mean of three
separate assays (in all cases with a SD #10% of the mean). Expression levels of transfected AU5-hShoc2 constructs were detected by immunoblotting
whole cell extracts (WCL) with the appropriate anti-AU5 antibody, and total Shoc2 expression was assessed by re-blotting of the same filters against anti-
Shoc2 rabbit polyclonal antibody and using tubulin detection as control. In each point-time, the protein levels of Shoc2 were normalized versus tubulin
amount and vector sample (-). Results were similar in three independent experiments.
doi:10.1371/journal.pone.0114837.g001
Shoc2 Is Essential for PC12 Cell Differentiation
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intensity and/or the duration of ERK activation elicited by FGF and EGF
stimulation.
To assess the relevance of Shoc2 in the RTK-ERK pathway, we transfected the
above cells with siRNA oligonucleotides for Shoc2. A sharp reduction was
observed both, in the expression of Shoc2 protein levels (Fig. 2A), and the
amount of mRNA (Fig. 2B), compared to HEK293T cells transfected with control
siRNA. This effect was clearly Shoc2-specific, since we show no alteration in the
protein levels of other ERK activation-pathway members such as Grb2, Ras, Raf,
MEK, and ERK (Fig. 2A). Shoc2 knockdown reduced phospho-ERK levels after
stimulation with FGF (Fig. 2A), or EGF (data not shown), at a rate proportional
to the decrease in Shoc2 levels. In addition, a similar reduction rates were
observed in phospho-MEK levels (Fig. 2A). The effects of Shoc2 knockdown on
FGF/EGF-induced MEK and ERK activation support the role of Shoc2 as an
essential positive-regulator of the RTK-ERK pathway.
Fig. 2. Shoc2 depletion reduces phospho-ERK and phospho-MEK levels induced by RTK activation. HEK293T cells were transiently transfected
(100 nM) with either control siRNA (siRNA-Control) or human Shoc2-specific siRNA (siRNA-Shoc2). At 48 h post-transfection, cells were serum-starved for
18 h and then incubated with vehicle (0), or 5-25 ng/ml FGF for 10 min. (A), endogenous Shoc2 expression was assessed, from the cell lysates, by
immunoblot using anti-Shoc2 rabbit polyclonal antibody and normalized to tubulin levels, expressed as a percentage (corresponding to the mean of five
separate assays, in all cases with a SD #10% of the mean). The specific effect of the siRNA-Shoc2 was tested throughout detection of Grb2, Ras, C-Raf,
ERK and MEK protein levels, by immunoblot of the cell lysates with the corresponding antibodies. Cell lysates were also analyzed by immunoblot using anti-
p-ERK/ERK, and anti-p-MEK/MEK antibodies (bottom panels); in each case, fold increase denotes the ratio p-ERK/ERK, and p-MEK/MEK levels estimated
as the mean of five separate assays (in all cases with a SD #10% of the mean). (B), the expression of Shoc2 was assessed by qRT-PCR. Data represents
the mean ¡ SD of four independent experiments. The detection of GAPDH (normalization control) was performed using specific primers. Results were
calculated by the 2-DDCT method. *P#0.001 compared with siRNA-control; bars show SD.
doi:10.1371/journal.pone.0114837.g002
Shoc2 Is Essential for PC12 Cell Differentiation
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Ectopic overexpression of Shoc2 enhances EGF-dependent PC12
cell differentiation
ERK signaling duration is a limiting step for the different biological effects of EGF
versus NGF in PC12 cells [2, 5, 6]. It is tempting to speculate that anything that
increases the duration of EGF-dependent ERK activity could modify the EGF
effects in PC12 cells. Since Shoc2 overexpression increased the duration of EGF-
induced ERK activation (Fig. 1B), we tested whether Shoc2 overexpression in
PC12 cells modified the EGF-induced biological fate of these cells. We compared
the percentage of cells showing neurites after EGF treatment in PC12 cells
transfected with GFP + AU5-hShoc2 versus GFP + empty vector (Fig. 3A-B). The
percentage of GFP-positive PC12 cells showing neurite outgrowth after EGF
treatment was significantly increased in cells overexpressing Shoc2 (Fig. 3C).
Ectopic overexpression of Shoc2 alone (without EGF or NGF stimulation) was
unable to elicit PC12 differentiation (not shown). These results suggest that Shoc2
protein modulates the outcome of EGF signaling on PC12 differentiation.
Shoc2 downregulation reduces both NGF-induced PC12
differentiation and ERK activation
Shoc2 overexpression in PC12 cells had no effect on NGF-stimulated neurite
outgrowth (not shown), probably due to the highly sustained NGF-dependent
ERK activation in these cells [2, 5, 6]. Shoc2 could nevertheless be an important
factor in NGF-induced PC12 differentiation, given its role in RTK-dependent
ERK activation (Figs. 1 and 2). To test Shoc2 effects on PC12 cell differentiation,
we downregulated their endogenous levels by shRNA. We transfected PC12 cells
with various bi-cistronic expression plasmids carrying specific shRNA to silence
rat Shoc2, together with cDNA for GFP, and performed a morphological analysis
of transfected GFP-positive/shRNA PC12 cells. We observed a sharp reduction in
Shoc2 protein levels in cells transfected with plasmids 2 and 3 (70% and 80%,
respectively) as compared to cells transfected with control shRNA (Fig. 4A–B).
Analysis of NGF-induced neurite outgrowth in PC12 cells transfected with
shRNA-Shoc2 expression plasmids (2 and 3) or with control shRNA (Fig. 4C)
showed that shRNA-Shoc2 significantly decreased the percentage of cells with
neurites (Fig. 4D). These results indicate that Shoc2 knockdown blocks NGF-
promoted PC12 cell differentiation. This reduction of Shoc2 protein levels in
PC12 cells also correlated with lower ERK activation after NGF stimulation
(Fig. 5A), but had no effect on other kinases such as AKT or GSK3 (Fig. 5B–C),
supporting Shoc2 specificity in the ERK pathway. These results show that Shoc2 is
necessary for appropriate ERK activation and neural differentiation of PC12 cells
triggered by neurotrophins such as NGF.
Shoc2 Is Essential for PC12 Cell Differentiation
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Discussion
The extracellular signal-regulated kinase (ERK) signaling pathway is functionally
relevant in converting extracellular stimuli into a wide range of cell responses,
including proliferation, differentiation, and survival of normal and malignant cells
[2, 21, 22, 23]. ERK-(1/2) are activated by mitogens and are usually upregulated in
human tumors [24] and in a class of developmental disorders, referred as
RASopathies, such as Noonan and LEOPARD syndromes [25]. In this pathway,
Ras (H-, N- or K-) activation by GTP-loading elicits the plasma membrane
recruitment of Raf (A-, B- or C-) that phosphorylates and activates to the dual
specificity kinases MEK1/2, which then subsequently phosphorylates and activates
Fig. 3. Shoc2 overexpression increases EGF-induced PC12 differentiation. A), PC12 cells were co-transfected with plasmids pCEFL-KZ-GFP (0.3 mg)
and pCEFL-KZ-AU5 (0.7 mg) (top: GFP + EGF) or pCEFL-KZ-GFP (0.3 mg) and pCEFL-KZ-AU5-hShoc2 (0.7 mg) (bottom: Shoc2-GFP + EGF). Transfected
PC12 cells were stimulated with EGF (100 ng/ml) for 72 h, fixed, and the presence of extending neurites was analyzed in GFP-positive cells by fluorescence
microscopy (right: white arrows). Total cells were visualized with transmitted-light (left). A process equal in length or greater than one cell body was
considered a neurite; bars, 10 mm. PC12 cells co-transfected with pCEFL-KZ-GFP and pCEFL-KZ-AU5-hShoc2 but not stimulated with EGF or NGF did not
have neurites (not shown). B), PC12 transfected cells (as in A) were stimulated with EGF (100 ng/ml) for 72 h, fixed. Cells were incubated with anti-AU5
monoclonal antibody for 1h at room temperature and, after several washes, were incubated with Alexa 488-conjugated secondary antibodies. The presence
of extending neurites was analyzed with transmitted-light (left-picture). PC12 cells overexpressing exogenous Shoc2 were detected as AU5-positive cells by
fluorescence microscopy (right-picture and white arrows). A process equal to or greater than one cell body in length was considered a neurite; bars, 10 mm.
C), histograms represent the percentage of transfected PC12 cells (GFP-positive: GFP vs Shoc2-GFP) with neurites after EGF treatment of panel A; values
are the mean of three separate assays, in which at least 50 GFP-positive cells/assay were analyzed (*P,0.01); bars show SD.
doi:10.1371/journal.pone.0114837.g003
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ERK1/2. The activity at each level of the pathway is fine-tuned through different
control steps, which then provoke the specificity of biological outcomes, both
throughout assembling signaling complexes at particular subcellular regions, and
by the control of signal dynamics [26, 27]. Among these ERK-pathway regulators
are the scaffold proteins, that tether and target signaling-complexes to different
subcellular locations [27, 28, 29]. These scaffolds include the kinase suppressor of
Ras1 (KSR1), paxillin, MEK partner 1 (MP1), IQ motif containing GTPase
activating protein 1 (IQGAP1), caveolin-1 [30, 31], and more recently to Shoc2.
The scaffold protein Shoc2 is conserved in all metazoans, with high binding
affinity to Ras and Raf proteins and a synergistic effect on RTK activation of the
ERK signaling pathway [12]. Shoc2 was firstly found in C. elegans as a positive
regulator of the Ras-pathway [10, 11], and this protein contains almost exclusively
Fig. 4. Shoc2 knockdown reduces NGF-elicited of PC12 cell differentiation. A), PC12 cells were nucleofected with shRNA-control-GFP plasmid
(ShRNA Control) or specific rat shRNA-Shoc2-GFP plasmids (ShRNA Shoc2 #1-3). At 48 h post-transfection, cell lysates were analyzed by immunoblot. B),
Shoc2 levels determined using anti-Shoc2 polyclonal antibody were normalized to total ERK levels, and expressed as a percentage (right). Results were
similar in two additional experiments. *P#0.001 and n.s. (not significant) compared with siRNA-control; bars show SD. C), PC12 cells nucleofected with
either shRNA-control-GFP plasmid (ShRNA Control) or specific rat shRNA-Shoc2-GFP plasmids (ShRNA Shoc2 (2) and (3)) were stimulated with 100 ng/ml
NGF for 72 h. After fixing, GFP-positive cells were detected by fluorescence microscopy (right: arrows) and total cells were visualized with transmitted light
(left). Extending processes equal in length or greater than two cell bodies were considered neurites; bars, 10 mm. D), histograms represent the percentage of
transfected PC12 cells (GFP-positive) with neurites after NGF treatment; values are the mean of three separate assays, in which at least 50 GFP-positive
cells/assay were analyzed (*ShRNA Shoc2 (2 or 3) vs ShRNA Control; P,0.01), bars show SD.
doi:10.1371/journal.pone.0114837.g004
Shoc2 Is Essential for PC12 Cell Differentiation
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leucine-rich repeats giving a curved solenoid structure suited for protein-protein
interaction [32]. The Shoc2 N-terminal domain binds to M-Ras and C-Raf,
whereas the C-terminal region of Shoc2 is responsible for Shoc2 targeting to late
endosomes [33]. Independently of the mechanism of action considered, either
accelerating Ras-Raf binding [12, 13, 14], or by Raf S259 dephosphorylation
throughout a ternary complex M-Ras/Shoc2/PP1c [16, 17], Shoc2 is essential for
the activation of Raf. In this context, Shoc2 expression is able to modulate both
ERK activation and resistance to apoptosis of B-RafV600E/N-RasQ61K melanoma
cells in the presence Raf inhibitor [34]. In addition, a naturally-occurring human
Shoc2 mutant was described that yields high phospho-ERK levels, causing a
Noonan-like syndrome [15]; this gain-of-function mutation in Shoc2 (S2G)
generates an aberrant N-myristoylation site, resulting in a Shoc2 protein
constitutively plasma membrane targeted [15] and unable to translocate to late
endosomes [35].
Here, we demonstrate that Shoc2 is an essential protein for ERK activation,
dependent on RTK stimulation. Our results show that downregulation of
endogenous Shoc2 expression (through specific siRNA and shRNA) significantly
reduced phospho-ERK levels after stimulation by FGF, EGF or NGF. Although the
role of Shoc2 on ERK activation in the EGFR signaling pathway has been
described [13, 16, 36], we found the same behavior for Shoc2 in other cell systems
and for other RTK-dependent signaling routes, such as fibroblast growth factor-
receptor (FGFR) and tropomyosin-related kinase (Trk) families. Our results not
only are concur with the description of a Shoc2 mutant involved in a Noonan-like
syndrome by deregulated ERK activation [15], but also with inhibition of the Ras-
ERK pathway by Erbin, another protein rich in leucine domains that blocks Shoc2
interaction with Raf and Ras, thus down-regulating ERK activation through
molecular binding between Erbin and Shoc2 [37, 38] that is enhanced by
Desmoglein-1 [39].
Based on to the critical role of Shoc2 in the RTK-ERK pathway, we showed that
ectopic overexpression of Shoc2 in epithelial cells was able to increase phospho-
ERK levels evoked by FGF or EGF. We also found that Shoc2 overexpression
produced persistent ERK activation, with an increase in duration of the effect of
$240 min post-EGFR stimulation. Evidences indicate that differences in ERK
activity duration produce variations in signaling that regulate cell fate. ERK
signaling duration is a limiting step for the different biological effects of EGF
versus NGF in PC12 cells [1, 2]. In this cell system, EGF induces rapid, transient
ERK activation, eliciting proliferation rather than neurite outgrowth [2]; in
contrast, NGF induces rapid, sustained ERK phosphorylation that leads to PC12
Fig. 5. Shoc2 knockdown reduces NGF-induced ERK activation in PC12 cells. PC12 cells nucleofected with shRNA-control-GFP plasmid (ShRNA
Control) or specific rat shRNA-Shoc2-GFP #3 plasmid (ShRNA Shoc2) were stimulated with 100 ng/ml NGF for the times indicated. In each assay, 2 mg
PC12 cell extracts were analyzed by xMAP technology in a Luminex-200 platform for quantitative and simultaneous detection of phospho-ERK (pTpY183/
185) and total ERK protein (Panel A), phospho-AKTand total AKT (Panel B) or phospho-GSK3 and total GSK3 protein (Panel C). Histograms show the ratio
of p-ERK/ERK (Panel A), p-AKT/AKT (Panel B) or p-GSK3/GSK3 levels (Panel C) after the indicated time of NGF stimulation; values are the mean of three
separate assays performed in duplicate (*P#0.001), bars show SD.
doi:10.1371/journal.pone.0114837.g005
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differentiation [2, 5, 6]. It is tempting to speculate that anything that increases the
duration of EGF-dependent ERK activity could modify the EGF effects in PC12
cells. Shoc2 overexpression produces more persistent EGF-dependent ERK
activation, and also enhances EGF-induced neurite outgrowth in PC12 cells.
Although this biological effect is not dramatic, the results obtained were
statistically significant and are in agreement with the idea that duration of ERK
activity is critical for PC12 cell fate.
Our data suggest that endogenous Shoc2 could also be implicated in
differentiation processes. Although Shoc2 overexpression in PC12 cells had no
effect on NGF-stimulated neurite outgrowth, probably due to the highly sustained
NGF-dependent ERK activation in these cells [2, 5, 6], Shoc2 knockdown
significantly reduced both NGF-induced ERK activation and neurite outgrowth.
Our data therefore indicate that the Shoc2 scaffold protein is essential for
appropriate ERK activation and neural differentiation of PC12 cells triggered by
neurotrophins such as NGF. These results could be considered opposite to other
studies, where Shoc2 has been proposed as an anti-differentiation factor that
stimulates proliferation for maintenance of self-renewal in neural progenitors cells
(NPC) through modulation of the Ras-ERK pathway [40]. However, it is known
that the Ras-ERK pathway elicits both inhibition of differentiation and activation
of proliferation in NPC [40, 41]. Obviously, PC12 are not biologically comparable
to NPC, but in both cases Shoc2 is absolutely critical for the sustained
functionality of the Ras/Raf/MEK/ERK pathway. Shoc2 probably is necessary to
maintain the proliferation and preventing differentiation in stem cells (especially
in response to bFGF and EGF) [39, 40]; but either in other lineage cells (such as
PC12, with higher differentiation level), or with other stimuli (such as NGF), the
Shoc2 role can be different. Same situation occurs with Spry2 (other docking/
scaffold protein modulator of the ERK pathway): while Spry2 inhibits the
differentiation of PC12 pheochromocytoma cells in response to FGF [42], it
promotes FGF-induced differentiation of C2C12 myoblasts [43], or it is involved
in the emergence of biased EGF signaling in the progeny of dividing neural stem
cells [44]. All these data (including our results) highlight the complex network of
molecular interactions stablished among the Ras/Raf/MEK/ERK pathway and its
docking/scaffold protein modulators, according to each cell lineage context and
the response to different stimuli.
The observation of the same number of GFP-PC12 positive cells at the end of
the differentiation assay, independent of their transfection status with shRNA-
control-GFP or shRNA-Shoc2-GFP plasmids (not shown), suggests that Shoc2
downregulation does not affect PC12 cell viability. These results concur with
previous reports indicating that PC12 cell survival does not require Ras-ERK
pathway activity, but it is instead dependent on PI3K signaling [45] which is
unaltered by Shoc2 knockdown (Fig. 5).
The role of Shoc2 in differentiation processes could explain both the effects of a
dominant mutant form of this protein in developmental disorders such as the
Noonan-like syndrome [15], and the defects of the atrioventricular canal that
cause early embryonic lethality when the Shoc2/Sur8 gene is inactivated in mouse
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endothelial cells [46]. Besides being a scaffold protein essential for the RTK-
dependent ERK activation pathway, Shoc2 could have other roles due to its
presence in nuclei [15] that we have observed during PC12 differentiation
(Martinez N et al., manuscript in preparation).
In conclusion, our data support positive modulation by Shoc2 of RTK-induced
ERK activation. The functional role of this protein could be relevant in the context
of variations in Ras-Raf-ERK signaling that regulate cell differentiation processes.
Future studies might show Shoc2 protein to be useful as target for the design of
new therapeutic drugs for several diseases.
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